Literature DB >> 15751076

Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept.

Satish Rachapalli, Simon O'Daunt.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15751076     DOI: 10.1002/art.20876

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  7 in total

Review 1.  [Infectious complications of biologic therapy in patients with rheumatoid arthritis].

Authors:  D Meyer-Olson; K Hoeper; R E Schmidt
Journal:  Z Rheumatol       Date:  2010-12       Impact factor: 1.372

Review 2.  [Listeriosis in adults - case reports and review of the literature].

Authors:  Claudia Metelmann; Katrin Schulz; Rotraud Geldschläger-Canda; Sebastian Plötz; Werner Handrick
Journal:  Wien Klin Wochenschr       Date:  2010-06-23       Impact factor: 1.704

3.  Listeriosis in a Metropolitan Hospital: Is Targeted Therapy a Risk Factor for Infection?

Authors:  Fanfan Xing; Simon K F Lo; Susanna K P Lau; Patrick C Y Woo
Journal:  Front Med (Lausanne)       Date:  2022-04-29

4.  [Arthritis due to Listeria monocytogenes].

Authors:  W Handrick; I Schwede; T Tomalik; F Berthold
Journal:  Z Rheumatol       Date:  2008-02       Impact factor: 1.372

5.  Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

Authors:  J B Galloway; K L Hyrich; L K Mercer; W G Dixon; A P Ustianowski; M Helbert; K D Watson; M Lunt; D P M Symmons
Journal:  Ann Rheum Dis       Date:  2011-07-21       Impact factor: 19.103

6.  Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.

Authors:  Filip De Keyser
Journal:  Curr Rheumatol Rev       Date:  2011-02

7.  The safety of etanercept for the treatment of plaque psoriasis.

Authors:  Kim A Papp
Journal:  Ther Clin Risk Manag       Date:  2007-06       Impact factor: 2.423

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.